AKT1 and cancer: Due to a negative feedback loop [33], inhibition of mTORC1 can induce AKT S473 phosphorylation in a subset of cancer cell lines and patient tumors [34–36], and therefore activation of AKT S473 might attenuate tumor responses [33,37].